Cost-effectiveness of the sequential application of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia
暂无分享,去创建一个
J. Radich | U. Siebert | S. Schmidt | D. Brixner | B. Jahn | D. Stenehjem | G. Gastl | D. Wolf | G. Sroczynski | U. Rochau | A. Conrads-Frank | M. Kluibenschaedl